UTSW study provides a potential avenue for the development of new antivirals against influenza

Reviewed by Emily Henderson, B.Sc.Jun 20 2022

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands. The findings were published in PNAS.

"These results uncover new strategies for interfering with influenza virus replication, providing a potential avenue for the development of new antivirals against influenza," said Beatriz Fontoura, Ph.D., Professor of Cell Biology at UT Southwestern, whose lab studies the interplay between RNA viruses, such as influenza A virus, with their hosts. The study was led by Dr. Fontoura, together with first author and postdoctoral fellow Shengyan Gao, Ph.D., and Melanie H. Cobb, Ph.D., Professor of Pharmacology.

To replicate, influenza virus takes over parts of the host cell nucleus known as nuclear speckles, which then provide the virus an environment to express its genes. Dr. Fontoura and her colleagues, including experts in cell biology, molecular biology, and pharmacology, identified a novel role in regulating nuclear speckle assembly and function for the TAO2 kinase – a protein involved in transferring phosphate groups to other proteins.

We found that TAO2 is needed to maintain the physical integrity and function of nuclear speckles. Among the functions of nuclear speckles is regulation of key steps in gene expression, which are usurped by influenza virus at these compartments to support viral replication. Consequently, by down-regulating TAO2 levels – or its kinase activity – we were able to inhibit influenza virus replication without causing major toxic effects to the host cell."

Dr. Beatriz Fontoura, Ph.D., Professor of Cell Biology, UT Southwestern

Other UTSW researchers who contributed to this study include Matthew Esparza, Ishmael Dehghan, Ke Zhang, Kimberly Batten, Tolga Cagatay, Jerry W. Shay, Elizabeth J. Goldsmith, and Zhijian "James" Chen.

Dr. Goldsmith holds the Patti Bell Brown Professorship in Biochemistry. Dr. Shay is a Distinguished Teaching Professor and holds the Southland Financial Corporation Distinguished Chair in Geriatrics. Dr. Chen is Professor of Molecular Biology and Director of the Center for Inflammation Research at UTSW, a Howard Hughes Medical Institute Investigator, and winner of the 2019 Breakthrough Prize in Life Sciences as well as holder of the George L. MacGregor Distinguished Chair in Biomedical Science. Dr. Cobb holds the Jane and Bill Browning, Jr. Chair in Medical Science. Drs. Chen and Cobb are members of the National Academy of Sciences.